- Novo Nordisk cyberattack exposed pseudonymized clinical trial patient data (IDs, biomarkers, lifestyle factors)
- Company insists no direct PII was leaked, reducing immediate risk of phishing or identity misuse
- Systems shut down for containment; third‑party experts investigating, core operations remain unaffected
Novo Nordisk, one of the biggest pharmaceutical companies in the world, has confirmed it recently suffered a cyberattack in which it lost sensitive data belonging to clinical trials patients.